publication date: May. 25, 2018

In Brief

Dan Theodorescu named director of Cedars-Sinai cancer center

Dan Theodorescu was named director of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai.

Theodorescu, a translational researcher and an expert in bladder cancer, will direct the oncology enterprise at Cedars-Sinai.

Theodorescu, who assumes his post July 1, said he will focus on what he describes as three revolutions shaping modern cancer care: precision medicine, the use of Big data to solve research and treatment questions, and employing population health ideas to improve the health of entire populations while reducing health disparities.

“As a highly accomplished clinician-scientist who has made major cancer therapeutic discoveries, Dr. Theodorescu is an ideal national leader to propel our flourishing clinical, research and community cancer program to further levels of excellence in quality management and outstanding scholarship,” Shlomo Melmed, executive vice president of academic affairs and dean of the medical faculty at Cedars-Sinai, said in a statement.

Theodorescu has served since 2010 as director of the University of Colorado Comprehensive Cancer Center. Also, he has been a professor of surgery and pharmacology in the system. During his eight years at the University of Colorado, he has overseen the only NCI-designated cancer center in the state, and twice led the successful renewal of the center’s NCI support grant.

He led the initiative to bring the cancer center into the National Comprehensive Cancer Network and the effort to secure state funding for the center. 

In his university post, Theodorescu translated science into novel medicines and biomarkers for clinical applications.

“I’m excited to join a great institution that can be instrumental in the revolutions that are shaping 21st-century cancer medicine,” Theodorescu said in a statement. “Cedars-Sinai is poised to … Continue reading Dan Theodorescu named director of Cedars-Sinai cancer center

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.